Danaher Purchases Iris For $355 Million In Expansion Bid

Danaher Purchases Iris For $355 Million In Expansion Bid

The healthcare sector is picking up due to several factors, and this increase in activity has proven to be a boon for many healthcare related companies. Danaher Corporation (NYSE:DHR) is just one of the companies which has profited from this mini boom in the healthcare field.

Danaher Purchases Iris For $355 Million In Expansion Bid

According to Reuters, Danaher Corporation (NYSE:DHR) has announced plans to purchase IRIS International, Inc. (NASDAQ:IRIS)for $355 million, which will add to its expanding medical diagnostics branch. This is not the first such acquisition for Danaher Corporation (NYSE:DHR), as Reuters points out, the company acquired Beckman Coulter just last year. The $5.8 billion purchase of this company, helped double second quarter sales for Danaher Corporation (NYSE:DHR)’s life sciences and diagnostics segments.

Mohnish Pabrai: 6.5x Return On Deep Value Turkish Stock [2020 Letter]

Mohnish PabraiIn his year-end letter to investors, Mohnish Pabrai, the Managing Partner of Pabrai Investment Funds, explained that 2020 had more impact on his way of thinking about the market than any other year since 1999. Q4 2020 hedge fund letters, conferences and more Following last year's lessons, Pabrai explained he has decided to move away Read More

Danaher Corporation (NYSE:DHR) has been very aggressive this year as well, having bought out 8 companies since the first of the year. The medical giant has spent almost $1 billion so far, and claims to have upt to $5 billion in its coffers, slated for this type of buyout and acquisition. This $5 billion buyout fund may be spent over the next two years.

According to reports, Danaher Corporation (NYSE:DHR) will pay $19.50 cash for each share of IRIS International, Inc. (NASDAQ:IRIS), which is a 45.3 % premium on the stock’s Friday closing price. IRIS International, Inc. (NASDAQ:IRIS) makes tests for analyzing urine and blood samples, and will be woven into the company’s Beckman Coulter Diagnostics unit. This purchase will give the diagnostics unit of Danaher Corporation (NYSE:DHR), an even bigger push towards profit. The addition of IRIS International, Inc. (NASDAQ:IRIS) will allow the company to tap into markets it has not yet reached, and the news of the buyout could prove to be a major plus for Danaher Corporation (NYSE:DHR) in the near future.

Danaher Corporation (NYSE:DHR) shares have remained flat on the news, while IRIS International, Inc. (NASDAQ:IRIS) shares jumped by 45% on the news of the deal, which should close in the fourth quarter.

No posts to display